14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $36.78 $42.85 Wednesday, 24th Apr 2024 CLDX stock ended at $37.02. This is 1.99% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.53% from a day low at $36.96 to a day high of $37.90.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Aug 14, 2023 $29.87 $31.10 $29.35 $31.07 338 184
Aug 11, 2023 $30.49 $31.17 $30.03 $30.23 341 865
Aug 10, 2023 $30.65 $32.08 $30.10 $30.55 455 894
Aug 09, 2023 $28.11 $30.53 $27.52 $30.52 890 690
Aug 08, 2023 $32.68 $33.14 $32.33 $32.41 307 442
Aug 07, 2023 $33.70 $33.70 $32.29 $32.65 384 404
Aug 04, 2023 $33.94 $34.21 $33.57 $33.64 144 991
Aug 03, 2023 $34.35 $34.83 $33.24 $33.79 155 164
Aug 02, 2023 $34.30 $34.75 $33.48 $34.43 310 948
Aug 01, 2023 $35.22 $35.60 $34.45 $34.76 287 350
Jul 31, 2023 $34.55 $35.40 $33.93 $35.36 209 164
Jul 28, 2023 $34.60 $35.61 $34.28 $34.70 356 222
Jul 27, 2023 $36.11 $36.11 $33.78 $34.28 486 888
Jul 26, 2023 $36.87 $37.17 $35.12 $35.86 392 975
Jul 25, 2023 $37.40 $37.75 $36.92 $36.96 310 350
Jul 24, 2023 $36.41 $37.49 $36.15 $37.40 404 452
Jul 21, 2023 $37.33 $37.34 $36.09 $36.41 315 201
Jul 20, 2023 $37.15 $37.60 $36.57 $37.04 319 789
Jul 19, 2023 $36.73 $37.65 $36.36 $37.07 293 174
Jul 18, 2023 $37.03 $38.13 $36.01 $36.43 279 869
Jul 17, 2023 $37.32 $38.33 $36.93 $36.94 385 485
Jul 14, 2023 $37.42 $37.57 $36.41 $37.29 272 307
Jul 13, 2023 $36.40 $37.91 $36.01 $37.46 483 491
Jul 12, 2023 $36.26 $36.76 $35.69 $36.37 462 252
Jul 11, 2023 $36.55 $36.76 $35.58 $36.01 204 008
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT